NICA fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Nanologica AB engages in the research and development of pharmaceutical products. It operates through Chromatography and Drug Development segments. The Chromatography segment include separation method based on the fact that different substance pass through a chromatography column at different paces. The Drug Development segment comprises development of new drugs or improving existing drugs on the market. The company was founded by Alfonso Garcia-Bennett in 2004 and is headquartered in Sodertalje, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
NICA does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company